Babcock International Group PLC Publication of a Prospectus (3269K)

TIDMBAB

RNS Number : 3269K

Babcock International Group PLC

20 September 2016

Babcock International Group PLC

20 September 2016

Babcock International Group PLC

Publication of Base Prospectus

20 September 2016

The following base prospectus (the "Prospectus") has been approved by the UK Listing Authority and is available for viewing:

The Prospectus dated 19 September 2016 relating to the Babcock International Group PLC GBP1,800,000,000 Euro Medium Term Note Programme.

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3269K_-2016-9-20.pdf

Documents incorporated by reference into the Prospectus: the audited consolidated annual financial statements, together with the accompanying notes and auditor's reports, contained in the annual reports of Babcock International Group PLC for the years ended 31 March 2016 and 31 March 2015 (set out on pages 136 to 201 and 126 to 182, respectively, of the 2016 and 2015 annual reports of Babcock International Group PLC).

http://www.rns-pdf.londonstockexchange.com/rns/3269K_1-2016-9-20.pdf

A copy of the Prospectus and the documents incorporated by reference therein will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Kate Hill - Head of Investor Relations

Babcock International Group PLC

Address: 33 Wigmore Street, London W1U 1QX

Telephone: [phone]

Email: [e-mail]

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Prospectus have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

This information is provided by RNS

The company news service from the London Stock Exchange

END

PDIBGGDCSXDBGLG

(END) Dow Jones Newswires

September 20, 2016 06:37 ET (10:37 GMT)